Navigation Links
Helix BioPharma Provides Updates on Topical Interferon Alpha-2b and L-DOS47 Following Pre-IND Meetings With the U.S. FDA
Date:10/6/2009

n Germany. The pharmacokinetic trial will enroll up to 28 patients in order to obtain a minimum of 12 patients for evaluation for the primary study endpoint. Helix plans to proceed with filing its Phase II/III IND if sufficient positive data are obtained from the first 12 patients completing the study, and all other study findings are positive. If required, Helix may expand the data set beyond the first 12 patients if the results indicate more data are needed. Preliminary findings from patients enrolled so far in this study show no significant systemic interferon alpha-2b exposure. While the study is progressing, enrollment to date has been slower than previously anticipated. Given the recruiting challenges to date, the Company has revised its timeline for the pharmacokinetic study. In order to enhance the patient recruitment rate, the Company intends to open additional clinical sites during the Company's second quarter of fiscal 2010. Assuming the patient recruitment rate improves as planned, Helix now expects it will take until the end of its third quarter of fiscal 2010 for the 12 minimum required patients to complete the study, and up to the end of its first quarter of fiscal 2011 for all 28 patients to do so.

Helix has also confirmed that it must successfully complete its ongoing, scale-up, GMP engineering batch manufacturing and preliminary stability testing program before filing its U.S. Phase II/III IND.

Given the anticipated timeline for the pharmacokinetic study activities, and assuming successful completion of the scale-up GMP engineering batch manufacturing, Helix now projects that its U.S. Phase II/III IND filing will occur, at the earliest, in its fourth quarter of fiscal 2010. This revised timeline is subject to the successful and timely completion of these activities and assumes that no events occur which could cause further delay.

As part of the pre-IND meeting, Helix has also confirmed its previously
'/>"/>

SOURCE Helix BioPharma Corp.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Helix Receives Approval to Open Sites in Germany for its Ongoing Clinical Trial With Topical Interferon Alpha-2b in Patients With Ano-Genital Warts
2. J. Craig Venter, Ph.D. Receives Double Helix Medal from Cold Spring Harbor Laboratory
3. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
4. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results
5. Nabi Biopharmaceuticals Announces Continued Positive NicVAX Phase 2b Data at Nine Months
6. Keryx Biopharmaceuticals to Present at William Blair & Company Small-Cap Growth Stock Conference
7. Morria Biopharmaceuticals Plc Initiates Phase I Clinical Study of MRX-4 in Allergic Rhinitis
8. Keryx Biopharmaceuticals, Inc. Announces Positive Preliminary Phase 2 Data on KRX-0401 in Patients with Chemo-Insensitive Rare Sarcoma
9. Nabi Biopharmaceuticals Announces Successful Completion of NicVAX(R) Phase 2b Trial; Drug Shows Statistically Significant Rates of Smoking Cessation and Continuous Long-Term Smoking Abstinence at 12 Months
10. Inspiration Biopharmaceuticals Announces Filing of IND for Novel Recombinant Factor IX Product, IB1001, for the Treatment of Hemophilia B
11. Immunosyn Announces Biozyme Labs Receipt of MHRA Manufacturing License Approval in Europe for the Biopharmaceutical SF-1019
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/12/2014)... , September 12, 2014 ... Market by Application [Beverages (Alcoholic, CSD, Sports & Energy ... Pet Food, Meat & Seafood)], by Material (Aluminum ... by MarketsandMarkets, defines and segments the Food & ... of each application in terms of volumes and ...
(Date:9/12/2014)... , Sept. 12, 2014 /PRNewswire-iReach/ -- 9 th ... 22-24, 2014 – Bethesda, MD ... http://www.fdanews.com/9thInspectionsSummitEarlyBird   Photo - http://photos.prnewswire.com/prnh/20140912/145652 ... for the next inspection than to get a glimpse ... during and after an inspection. Come to ...
(Date:9/12/2014)... 12, 2014 Research and Markets ... "Global Medical Technologies Market 2014-2018" report to ... a collective term for software solutions, medical devices, ... health. The Global Medical Technologies market covers active ... In vitro diagnostics technology, dental technology, electromechanical medical ...
Breaking Medicine Technology:Food & Beverage Metal Cans Market Worth $49.20 Billion by 2019 2Food & Beverage Metal Cans Market Worth $49.20 Billion by 2019 3Food & Beverage Metal Cans Market Worth $49.20 Billion by 2019 4FDAnews Announces: Early Bird Registration Discount Ends Sept.19 for 9th Annual Inspections Summit, Oct. 22-24, 2014 2FDAnews Announces: Early Bird Registration Discount Ends Sept.19 for 9th Annual Inspections Summit, Oct. 22-24, 2014 3Global Medical Technologies Market 2014-2018: Key Vendors are GE, Johnson & Johnson, Medtronic, Roche and Siemens 2Global Medical Technologies Market 2014-2018: Key Vendors are GE, Johnson & Johnson, Medtronic, Roche and Siemens 3
... and CAMPBELL, Calif. , May ... sophisticated risk characterization and personalized therapy guidelines for ... of advanced tests, offering an accompanying nutrition program, ... Director stated:  "With appropriate risk characterization and treatment, ...
... May 25 The U.S. Food and Drug Administration approved Lumizyme (alglucosidase ... a rare genetic disorder. , , ... http://www.newscom.com/cgi-bin/prnh/20090824/FDALOGO ) , , , ... an estimated 1 in every 40,000 to 300,000 births. Its primary symptom is ...
Cached Medicine Technology:Health Network Laboratories (HNL) Enters Into License Agreement With Hunter Laboratories to Provide HunterHeart Cardiovascular Disease Management Program. 2FDA Approves New Treatment for Late-Onset Pompe Disease 2FDA Approves New Treatment for Late-Onset Pompe Disease 3
(Date:9/15/2014)... Greenbelt, MD (PRWEB) September 15, 2014 With ... for Vascular Medicine can gain valuable insight to help personalize ... artery disease (PAD) . , The ideal approach to medicine ... doctor to predict how a patient will respond to specific ... identify a patient’s genetic makeup, allowing the physician to tailor ...
(Date:9/15/2014)... September 15, 2014 Marlton, New Jersey, ... , Stuart M. Goldstein, of the law firm of ... in obtaining the issuance of U.S. Patent No. 8,774,911 ... patent’s medically innovative design for a pedicle locator instrument ... New Jersey, a board certified neurosurgeon specializing in minimally-invasive ...
(Date:9/15/2014)... Aliso Viejo, California (PRWEB) September 15, 2014 ... themes and 3rd party plugins have announced a new Template ... is to offer our users a wide variety quality themes ... to our growing library," says Christian Austin, Pixel Film Studios ... our users will love.” , Qube features intuitive controls that ...
(Date:9/15/2014)... 2014 Fancyflyingfox.com, the distinguished wedding dress ... for beach wedding dresses . All clients can ... company’s website, up to 70 percent off. According to ... to all its loyal customers by launching the current ... more than 300 different styles of special occasion gowns ...
(Date:9/15/2014)... (PRWEB) September 15, 2014 Concox ... tracker and wireless communications equipment, is dedicated to bringing ... world. , Being the best-seller in Concox’s products, GT06N ... appealing to customers. GT06N is a mini and original ... It can be installed in the shelters on cars ...
Breaking Medicine News(10 mins):Health News:Center for Vascular Medicine Offers Genetic Testing For Personalized Vascular Care 2Health News:Patent Attorney Stuart M. Goldstein Helps Client Receive a Patent on a Surgical Device designed to Increase Accuracy and Safety in Vertebrae Repair and Attachment 2Health News:Patent Attorney Stuart M. Goldstein Helps Client Receive a Patent on a Surgical Device designed to Increase Accuracy and Safety in Vertebrae Repair and Attachment 3Health News:Patent Attorney Stuart M. Goldstein Helps Client Receive a Patent on a Surgical Device designed to Increase Accuracy and Safety in Vertebrae Repair and Attachment 4Health News:Patent Attorney Stuart M. Goldstein Helps Client Receive a Patent on a Surgical Device designed to Increase Accuracy and Safety in Vertebrae Repair and Attachment 5Health News:Announcing the Release of a New Template for Final Cut Pro X, The Qube Theme from Pixel Film Studios 2Health News:Great Discounts On Beach Wedding Dresses Announced By Fancyflyingfox.com Now 2Health News:iConcox GPS Vehicle Tracker GT06N Designed for Customers' Security 2
... versus Caucasian men when it comes to prostate cancer ... in African Americans, it is often more aggressive and ... social and biological factors influencing disparities among African-American men ... Research conference on The Science of Cancer Health Disparities ...
... make it tougher for them to function socially, study ... diagnosed with autism have more gray matter in their ... novel imaging technique to analyze brain structure. , The ... it harder for autistic children to learn how to ...
... Stress can ruin your whole day,... and your whole ... Americans annually suffer from occasional sleeplessness, and the,stress of ... and sleep are not comfortable bed partners," explains Cheryl,Myers, ... "But,many people don,t recognize that stress may be the ...
... Medicine Group Dr. Nicholas M., Halikis ... Systems., REDONDO BEACH, Calif., Nov. 28 ... to healthcare providers,today announced the election of Nicholas ... Dr. Halikis joins a distinguished Board that ...
... solution developed in response to evidence-based recommendations ... on improving drug labels, PHILADELPHIA, Nov. 28 You ... the container label says: "take one,tablet by mouth twice daily ... your medicine? This might be easy for you to answer, ...
... genX International, Inc and,IVFonline, LLC (genX ... products are being sold to some IVF ... distributed by genX International,and IVFonline. Therefore, genX ... Coda(R) products and genX International cannot,guarantee that ...
Cached Medicine News:Health News:Genetic and behavioral differences add to prostate cancer disparities 2Health News:Genetic and behavioral differences add to prostate cancer disparities 3Health News:Genetic and behavioral differences add to prostate cancer disparities 4Health News:Genetic and behavioral differences add to prostate cancer disparities 5Health News:Autistic Children Have More Gray Matter in Brains 2Health News:Autistic Children Have More Gray Matter in Brains 3Health News:Autistic Children Have More Gray Matter in Brains 4Health News:Reduce Stress Hormones to Beat Sleep Problems 2Health News:Prominent Orthopaedic Hand and Upper Extremity Surgeon Joins Radlink Board of Directors 2Health News:System of Simplified, Standardized Dosing Instructions for Prescription Medication Container Labels Proposed at Sixth Annual National Health Communication Conference 2Health News:System of Simplified, Standardized Dosing Instructions for Prescription Medication Container Labels Proposed at Sixth Annual National Health Communication Conference 3Health News:Warning - Beware of Counterfeit Coda(R) Products 2
... PoliPhase® is a biologically based ... two component system consisting of a ... the control of internal bleeding. ... readily flow on to a prepared ...
The DuraSeal System includes an innovative polyethylene glycol hydrogel sealant and applicator packaged in a single-use kit which can be stored at room temperature for convenience and quick preparati...
... DERMABOND* Topical Skin Adhesive gives you ... adhesive is intended for topical application only ... of wounds from surgical incisions, including punctures ... cleansed, trauma-induced lacerations. DERMABOND adhesive may be ...
... BD Cell-Tak™ Cell and Tissue Adhesive is ... Mytilus edulis (marine mussel). These proteins are ... by the mussel to anchor itself to ... Cell-Tak Cell and Tissue Adhesive is used ...
Medicine Products: